psalexa

Global Programmed Death-1 (PD-1) & Programmed Death Ligand-1 (PD-L1) Inhibitors Pipeline Analysis, Market Size, Share, Development, Growth and Demand Forecast to 2025 – Industry Insights by Drug (Opdivo, Keytruda, Tecentriq, Durvalumab, Avelumab), by Mechanism of Action (PD-1 Inhibitor, PD-L1 Inhibitor)

Published Report Code Available Format Pages
 January 2017  LS10752    168

Note: This report can also be updated as of date and delivered within 1-2 working days of purchase confirmation

Place an order

USD 4900
USD 5900
USD 7500
We use cookies to enhance your experience. By continuing to use this site you consent to our use of cookies. More info X